drug
PANTOPRAZOLE SODIUM
Marketedupdated 3mo agoby Knack Pharmaceuticals Inc
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 5all catalysts(14)
approval · 14
Jul 14, 2015
approval
PANTOPRAZOLE SODIUM — FDA approval
PANTOPRAZOLE SODIUM
→
Sep 16, 2019
approval
PANTOPRAZOLE SODIUM — FDA approval
PANTOPRAZOLE SODIUM
→
Sep 16, 2019
approval
PANTOPRAZOLE SODIUM — FDA approval
PANTOPRAZOLE SODIUM
→
Sep 16, 2019
approval
PANTOPRAZOLE SODIUM — FDA approval
PANTOPRAZOLE SODIUM
→
Sep 16, 2019
approval
PANTOPRAZOLE SODIUM — FDA approval
PANTOPRAZOLE SODIUM
→
Mar 5, 2021
approval
PANTOPRAZOLE SODIUM — FDA approval
PANTOPRAZOLE SODIUM
→
May 18, 2022
approval
PANTOPRAZOLE SODIUM — FDA approval
PANTOPRAZOLE SODIUM
→
Jul 28, 2022
approval
PANTOPRAZOLE SODIUM — FDA approval
PANTOPRAZOLE SODIUM
→
Oct 5, 2023
approval
PANTOPRAZOLE SODIUM — FDA approval
PANTOPRAZOLE SODIUM
→
Oct 1, 2025
approval
PANTOPRAZOLE SODIUM — FDA approval
PANTOPRAZOLE SODIUM
→
Oct 1, 2025
approval
PANTOPRAZOLE SODIUM — FDA approval
PANTOPRAZOLE SODIUM
→
Oct 1, 2025
approval
PANTOPRAZOLE SODIUM — FDA approval
PANTOPRAZOLE SODIUM
→
Oct 15, 2025
approval
PANTOPRAZOLE SODIUM — FDA approval
PANTOPRAZOLE SODIUM
→
Oct 15, 2025
approval
PANTOPRAZOLE SODIUM — FDA approval
PANTOPRAZOLE SODIUM
→
Trials studying PANTOPRAZOLE SODIUM
Patent cliff
source: FDA Orange Bookfirst barrier falls
Dec 7, 2026
108 days
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (2)
- Dec 7, 2026patentUS 7544370*PED108d
- Jun 7, 2026formulationUS 7544370
FDA exclusivities (1)
- Aug 12, 2027NPPNew Product (3y)356d
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 23m ago
Found something off?
comments(0)
5-min edit window · permanent after that